These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
779 related items for PubMed ID: 21164283
1. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6. Mukhopadhyay S, Katzenstein AL. Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283 [Abstract] [Full Text] [Related]
2. Optimal combination of immunohistochemical markers for subclassification of non-small cell lung carcinomas: A tissue microarray study of poorly differentiated areas. Noh S, Shim H. Lung Cancer; 2012 Apr; 76(1):51-5. PubMed ID: 21978426 [Abstract] [Full Text] [Related]
3. ΔNp63, CK5/6, TTF-1 and napsin A, a reliable panel to subtype non-small cell lung cancer in biopsy specimens. Zhao W, Wang H, Peng Y, Tian B, Peng L, Zhang DC. Int J Clin Exp Pathol; 2014 Apr; 7(7):4247-53. PubMed ID: 25120805 [Abstract] [Full Text] [Related]
13. Evaluation of napsin A, TTF-1, p63, p40, and CK5/6 immunohistochemical stains in pulmonary neuroendocrine tumors. Zhang C, Schmidt LA, Hatanaka K, Thomas D, Lagstein A, Myers JL. Am J Clin Pathol; 2014 Sep; 142(3):320-4. PubMed ID: 25125621 [Abstract] [Full Text] [Related]
14. Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings. Aikawa E, Kawahara A, Hattori S, Yamaguchi T, Abe H, Taira T, Azuma K, Kage M. Cancer Cytopathol; 2011 Oct 25; 119(5):335-45. PubMed ID: 21717589 [Abstract] [Full Text] [Related]
15. Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples. Terry J, Leung S, Laskin J, Leslie KO, Gown AM, Ionescu DN. Am J Surg Pathol; 2010 Dec 25; 34(12):1805-11. PubMed ID: 21107086 [Abstract] [Full Text] [Related]
16. Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non-small cell lung carcinomas using fine-needle aspiration cases. Sharma R, Wang Y, Chen L, Gurda GT, Geddes S, Gabrielson E, Askin F, Li QK. Hum Pathol; 2016 Aug 25; 54():8-16. PubMed ID: 27045515 [Abstract] [Full Text] [Related]
18. Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung. Whithaus K, Fukuoka J, Prihoda TJ, Jagirdar J. Arch Pathol Lab Med; 2012 Feb 25; 136(2):155-62. PubMed ID: 22288962 [Abstract] [Full Text] [Related]
20. The diagnostic value of TTF-1, CK 5/6, and p63 immunostaining in classification of lung carcinomas. Kargi A, Gurel D, Tuna B. Appl Immunohistochem Mol Morphol; 2007 Dec 25; 15(4):415-20. PubMed ID: 18091384 [Abstract] [Full Text] [Related] Page: [Next] [New Search]